CAVAGNA, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 2.583
EU - Europa 2.143
AS - Asia 1.005
SA - Sud America 5
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 5.747
Nazione #
US - Stati Uniti d'America 2.554
IE - Irlanda 1.003
CN - Cina 984
FI - Finlandia 265
UA - Ucraina 205
DE - Germania 188
IT - Italia 170
AT - Austria 129
SE - Svezia 76
GB - Regno Unito 36
BE - Belgio 34
CA - Canada 28
FR - Francia 23
IN - India 7
MK - Macedonia 4
TR - Turchia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
EC - Ecuador 3
NL - Olanda 3
DK - Danimarca 2
HK - Hong Kong 2
MU - Mauritius 2
NG - Nigeria 2
RU - Federazione Russa 2
AM - Armenia 1
BO - Bolivia 1
BR - Brasile 1
ES - Italia 1
EU - Europa 1
IQ - Iraq 1
JP - Giappone 1
MX - Messico 1
MY - Malesia 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
SG - Singapore 1
Totale 5.747
Città #
Dublin 989
Chandler 770
Jacksonville 324
Nanjing 286
Princeton 160
Lawrence 140
Helsinki 135
Wilmington 125
Nanchang 115
Vienna 109
Beijing 105
Medford 104
Shenyang 87
Hebei 80
Jiaxing 77
Changsha 75
Ann Arbor 55
Tianjin 54
Pavia 50
Hangzhou 49
Brussels 34
Milan 33
Boardman 31
Woodbridge 31
Norwalk 27
Fairfield 20
Toronto 19
Washington 17
Redwood City 11
Verona 11
Houston 10
San Francisco 9
Shanghai 8
Chicago 7
Auburn Hills 6
Jinan 6
Ningbo 6
Guangzhou 5
Ottawa 5
Berlin 4
Borås 4
Dearborn 4
Lanzhou 4
Redmond 4
Zhengzhou 4
Ashburn 3
Changchun 3
Chengdu 3
Des Moines 3
Falls Church 3
Moncalieri 3
Napoli 3
Orange 3
Quito 3
San Giuliano Milanese 3
Settimo Torinese 3
Abuja 2
Aosta 2
Bulgorello 2
Canberra 2
Canyon Country 2
Castelbuono 2
Collegno 2
Conegliano 2
Cupertino 2
Frankfurt am Main 2
Fremont 2
Genova 2
Gunzenhausen 2
Haikou 2
Hyderabad 2
Kunming 2
Lodi 2
Rome 2
Seattle 2
Turin 2
Vanzago 2
Aachen 1
Addison 1
Andover 1
Baghdad 1
Biella 1
Bolano 1
Bologna 1
Brunssum 1
Cedar Knolls 1
Chongqing 1
Costa Mesa 1
Den Haag 1
Edmonton 1
Esslingen am Neckar 1
Falkenstein 1
Fort St. James 1
Fuzhou 1
Genoa 1
Germignaga 1
Jinhua 1
Lincoln 1
Littleton 1
Livorno 1
Totale 4.307
Nome #
Prognostic value of antisynthetase antibodies in patients affected by polymiositis/dermatomyositis with interstitial lung disease 87
Association between anti-dsDNA titre increase and thymoma relapse 77
A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: a challenging clinical case in light of the current diagnostic criteria. 74
Interessamento cutaneo nella dermatomiosite 70
Spondiliti e spondilodisciti batteriche. 70
2-DE and LC-MS/MS for a Comparative Proteomic Analysis of BALf from Subjects with Different Subsets of Inflammatory Myopathies 69
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study 66
Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases 64
Anti-neutrophil cytoplasmic antibodies (ANCA) ( Review ) [Anticorpi anticitoplasma dei neutrofili (ANCA)] 64
Is it really infective endocarditis? Distinguishing systemic vasculitis from its mimics 64
Inflammatory myopathy in a patient with cutaneous findings of pityriasis rubra pilaris: a case of wong's dermatomyositis 63
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 63
Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. 61
Early electroretinografic changes in elderly RA patients treated with hydroxychloroquine 60
Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome. 60
Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. 60
Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 59
La poliangioite microscopica. 58
Anti-Ma2/Ta antibodies in a woman with primary lateral sclerosis-like phenotype and Sjogren syndrome 58
Autoantibodies to heterogeneous nuclear ribonucleoproteins. 57
Pain in arthritis 56
Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis. 56
Overuse of prescription and otc non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis and osteoarthritis. 56
Rheumatoid arthritis and renal light-chain deposition disease: long-term effectiveness of TNF-alpha blockade with etanercept 55
Predictors of response to anti-TNF therapy in RA patients with moderate or high DAS28 scores. 55
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome 55
Effects of anti-TNF alpha drugs on disability in patients with rheumatoid arthritis: Long-term real-life data from the Lorhen registry 53
A case of adult onset Still's disease treated with infliximab - Reply 53
Compressive cervical myelopathy due to massive periodontoid calcium pyrophosphate crystal deposition 52
Therapeutic options in Anti-Jo1 antisynthetase syndrome with interstitial lung disease. 52
Combined interventional sialendoscopy and intraductal steroid therapy for recurrent sialadenitis in Sjögren's syndrome: Results of a pilot monocentric trial 52
Diagnostic Arthrocentesis for Suspicion of Gout Is Safe and Well Tolerated 52
Biosimilars: Lights and shadows in rheumatology 51
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 51
Serologic Profile and Mortality Rates of Scleroderma Renal Crisis in Italy 50
Cardiovascular involvement in rheumatoid arthritis [L'interessamento cardiaco nell'artrite reumatoide] 50
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 50
Performance of classification criteria for gout in early and established disease 50
Pulmonary arterial hypertension in antisynthetase syndrome: comment on the article by Chatterjee and Farver. 49
Pain and rheumatology: An overview of the problem 49
Clinical and electrophysiological evaluation of peripheral neuropathy in rheumatoid arthritis. 48
Chromosomally integrated human herpesvirus 6 in a patient with systemic lupus erythematosus. 48
Biotechnological drugs: The breakthrough in autoimmune rheumatic conditions 48
Clinical features of ANCA-positive systemic lupus erythematosus: report of two cases. 48
Therapy of necrotizing arteritis | [La terapia delle vasculiti necrotizzanti] 47
"Emergency" Cochlear Implantation in Labyrinthitis Ossificans Secondary to Polyarteritis Nodosa: How to Face a Rare Entity 47
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine 47
Modulating the co-stimulatory signal for T cell activation in rheumatoid arthritis: Could it be the first step of the treatment? 46
New perspectives in the classification and treatment of systemic lupus erythematosus: the central role of kidney involvement] [Nuovi aspetti classificativi e terapeutici del lupus eritematoso sistemico: centralità dell'interessamento renale] 46
Atherosclerosis and rheumatoid arthritis: more than a simple association 46
Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis. 46
Undiagnosed connective tissue diseases High prevalence in pulmonary arterial hypertension patients 45
Clinical spectrum time course of interstitial pneumonia with autoimmune features in patients positive for antisynthetase antibodies 45
Clinical spectrum of anti-Jo-1-associated disease 45
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 45
Prescribing pattern of drugs in the treatment of osteoarthritis in Italian general practice: The effect of rofecoxib withdrawal 44
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 44
Brief Report: Validation of a Definition of Flare in Patients With Established Gout 44
Idiopathic inflammatory myopathies: Narrative review of unmet needs in clinical practice guidelines 44
Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases 43
Study for updated gout classification criteria: Identification of features to classify gout 43
The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: A Retrospective population-based study in Southern Italy 43
Capillary leak syndrome in a patient with cancer-associated anti-transcriptional intermediary factor 1γ dermatomyositis treated with rituximab 42
Clinical spectrum time course in anti jo-1 positive antisynthetase syndrome: Results from an international retrospective multicenter study 42
Miositi idiopatiche dell’adulto: analisi retrospettiva di 45 casi. 41
Clinical and electrophysiological evaluation of peripheral neuropathy in rheumatoid arthritis 41
Rheumatoid arthritis in beta-thalassemic trait: clinical, serologic and immunogenetic profile. 41
Long-term safety of abatacept in patients with rheumatoid arthritis 40
Early morpho-functional changes in patients treated with hydroxychloroquine: a prospective cohort study 40
Telemedicine: a useful tool but not the holy grail. Response to: 'Telemedicine will not keep us apart in the COVID-19 pandemic' by Perniola et al 40
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome 40
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis 40
Sinonasal Surgery in Wegener's Granulomatosis: Is It Time to Go On? 39
New criteria needed for antisynthetase syndrome 39
The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases 39
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 39
Patients with interstitial lung disease secondary to autoimmune diseases: How to recognize them? 39
Thrombocytopenia in idiopathic inflammatory myopathies: a case series analysis 38
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 38
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 38
Genetics and novel aspects of therapies in systemic lupus erythematosus 37
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 37
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 37
Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study 37
Successful treatment with baricitinib in a patient with refractory cutaneous dermatomyositis 37
CT-guided biopsy in the differential diagnosis of Sjogren syndrome associated cystic lung disease: A case of lung nodular AL-k amyloidosis 37
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis 37
One year in review 2019: idiopathic inflammatory myopathies 37
Infliximab in the treatment of adult Still's disease refractory to conventional therapy 36
Colony-stimulating factor-1: A potential biomarker for lupus nephritis 35
Polyarthrite rhumatoïde associée à un trait bêta-thalassémique : aspect clinique, sérologique et immunogénétique 35
Erratum: Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (Journal of Neurology (2014) 261 (438-440) DOI: 10.1007/s00415-013-7217-3) 33
Rare clinical manifestations in systemic lupus erythematosus: A review on frequency and clinical presentation 32
Inappropriate exercise-induced increase in pulmonary artery pressure in patients with systemic sclerosis 32
Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay 32
Real life picture of the use of intravenous immunoglobulins in idiopathic inflammatory myopathies: Results of a multicentric study 32
Prédicteurs de la réponse aux traitements anti-TNF chez les patients ayant une polyarthrite rhumatoïde avec des scores DAS28 modérés ou élevés 31
Pulmonary nocardiosis in a patient affected by anti-MDA5-positive amyopathic dermatomyositis under immunosuppressive therapy 31
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 31
Survey definitions of gout for epidemiological studies: Comparison with crystal identification as the gold standard 30
Totale 4.755
Categoria #
all - tutte 19.022
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.022


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019243 0 0 93 7 3 1 75 5 44 8 2 5
2019/20201.181 348 485 5 39 3 44 17 60 13 99 65 3
2020/2021512 45 35 17 46 14 55 2 92 52 66 68 20
2021/2022745 36 23 30 6 17 14 22 45 35 9 105 403
2022/20232.607 270 193 32 194 195 194 29 156 1.193 18 70 63
2023/2024366 121 203 42 0 0 0 0 0 0 0 0 0
Totale 6.089